CME Information

Accreditation

The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Designation

The Society of Surgical Oncology (SSO) designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Cancer surgeons and other clinicians providing care for patients with solid tumors.

Overall Educational Objectives

Upon completion of the activity, learners should be able to:

Describe disparities in surgical oncology care and quality improvement opportunities
Evaluate cases, including diagnosis, treatment, and outcomes in breast, colorectal/gastrointestinal, endocrine, hepato-pancreato-biliary, melanoma, sarcoma, and peritoneal surface malignancies
Explain strategies to improve the quality and value of care for surgical oncology patients
Identify the impact of neoadjuvant systemic therapy and radiation on surgical management of solid tumors
Incorporate new treatment strategies for surgical oncology, including management and early detection of metastatic disease

Disclaimer

The primary purpose of SSO 2025 Annual Meeting is educational. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty and the SSO disclaims any and all liability for damages to any individual attending this conference and for all claims which may result from the use of information, technologies, products and/or services discussed at the conference.